Novartis To Offer Zero-Profit Medicines For Covid-19 Treatment
July 16 2020 - 1:56AM
Dow Jones News
By Jessica Sier
Novartis AG said Thursday that it will offer medicines on a
zero-profit basis to financially-strained countries to assist in
the treatment of Covid-19 symptoms.
The Swiss pharmaceuticals company said the initiative will
include 15 medicines that help treat gastro-intestinal illness,
acute respiratory symptoms, pneumonia and septic shock for
low-income and lower-middle-income patients.
Novartis said the medicines will be made available to
governments, non-governmental organizations and other institutional
customers in up to 79 countries.
Write to Jessica Sier at jessica.sier@wsj.com
(END) Dow Jones Newswires
July 16, 2020 01:41 ET (05:41 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Novartis (NYSE:NVS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novartis (NYSE:NVS)
Historical Stock Chart
From Apr 2023 to Apr 2024